Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies (Q46882720)
scientific article published in January 2006
Language:
Current Data About Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies
(P31) (Q13442814)
(P248)
(P698) 16397263
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16397263

(P50) (Q373427)
(P1545) 9
(P248)
(P698) 16397263
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16397263

(Q40526741)
(P1545) 10
(P248)
(P698) 16397263
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16397263

(Q1045499)
(P1545) 7
(P1932) Carsten Bokemeyer
(P248)
(P698) 16397263
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16397263

(P304) 473-481
(P248)
(P698) 16397263
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16397263

(P407) (Q1860)

(P433) 1
(P248)
(P698) 16397263
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16397263

(P478) 66
(P248)
(P698) 16397263
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16397263

(P577) Sunday, January 1, 2006
(P248)
(P698) 16397263
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16397263

(P921) (Q27139135)
(P887)

(Q419940)
(P887)

(P1433) (Q326097)
(P248)
(P698) 16397263
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16397263

(P1476) "Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies" (language: en)
(P248)
(P698) 16397263
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16397263

(P2093) Marcus M Schittenhelm
(P1545) 1
(P248)
(P698) 16397263
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16397263

Sharon Shiraga
(P1545) 2
(P248)
(P698) 16397263
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16397263

Arin Schroeder
(P1545) 3
(P248)
(P698) 16397263
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16397263

Amie S Corbin
(P1545) 4
(P248)
(P698) 16397263
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16397263

Diana Griffith
(P1545) 5
(P248)
(P698) 16397263
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16397263

Francis Y Lee
(P1545) 6
(P248)
(P698) 16397263
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16397263

Michael W N Deininger
(P1545) 8
(P248)
(P698) 16397263
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16397263

other details
description scientific article published in January 2006

External Links
(P356) 10.1158/0008-5472.CAN-05-2050
(P698) 16397263